Could cause temporary or reversible harm; serious harm is unlikely.
cGMP Deviations
| Distributed by / for | H J Harkins Company Inc dba Pharma Pac |
| NDC | 52959-0003-10 |
| Full product label | Acetaminophen and Codeine Phosphate 300/30 mg tablet, packaged in: a) 10-count bottle (NDC 52959-0003-10), b) 12-count bottle (NDC 52959-0003-12), c) 14-count bottle (NDC 52959-0003-14), d) 15-count bottle (NDC 52959-0003-15), e) 16-count bottle (NDC 52959-0003-16), f) 20-count bottle (NDC 52959-0003-20), g) 30-count bottle (NDC 52959-0003-30), h) 60-count bottle (NDC 52959-0003-60), Rx Only, Mfg. Aurobindo; Repack: H.J. Harkins Co., Inc., Grover Beach, CA 93433 |
| Recalling firm | H J Harkins Company Inc dba Pharma Pac |
| Distribution | Product was distributed in CA and AZ. |
| Quantity | 9,000 tablets |
| Recall initiated | 2020-04-15 |
| Report date | 2020-04-22 |
| Recall completed | 2024-02-14 |
| Recall number | D-1246-2020 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Grover Beach CA United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗